Spots Global Cancer Trial Database for ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial
Official Title: Evaluation of Safety and Feasibility of the ICE-SENSE™, a Cryotherapy Device for Office-based Ultrasound-guided Treatment of Breast Fibroadenoma
Study ID: NCT00910312
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether the Ice-Sense, a novel cryotherapy system (a system that freezes tissues), is safe and effective in the treatment of benign breast tumors such as fibroadenoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Oncogynecological Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, , Czechia
Department of Obstetrics and Gynecology, University Hospital of Heidelberg, Heidelberg, , Germany
Department of Obstetrics and Gynecology, University Hospital of Tuebingen, Tübingen, , Germany
Assuta medical centers, Haifa, , Israel
Contact Details
Name: Rafi Klein, Dr.
Affiliation:
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
